Condition: Frailty at Older Adults · Ovarian Cancer · Endometrial Cancer · Sponsor: Wake Forest University Health Sciences
The purpose of this study is to evaluate changes in the electronic Frailty Index (eFI) score following 3-4 cycles of neoadjuvant chemotherapy (NACT) in participants with advanced ovarian and endometrial cancer.
This description comes directly from the study's public registry record.
Sydney McEntire, RN · 336-713-5879 · sydney.mcentire@advocatehealth.org
Always discuss trial participation with your own doctor first.
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07220512